Who Owns QNTM?

Quantum BioPharma Ltd. — Institutional Ownership & 13F Holdings

$4.40

+0.81 (+22.58%)

Market Cap

$12.9M

Shares Outstanding

4,117,651

Institutional Holders

14

Total Inst. Value

$551K

% of Float Held

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1AdvisorShares Investments LLC$391K48,990
2J.W. COLE ADVISORS, INC.$97K12,590
3Tower Research Capital LLC (TRC)$25K3,195
4MORGAN STANLEY$19K2,532
5UBS Group AG$12K1,614
6THOMPSON INVESTMENT MANAGEMENT, INC.$2K325
7Cetera Trust Company, N.A$2K250
8SBI Securities Co., Ltd.$1K157
9GROUP ONE TRADING LLC$887115
10Activest Wealth Management$11615

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

Related Stocks

Frequently Asked Questions

How many institutional investors hold QNTM?

As of Q1 2025, 14 institutional investors report holding QNTM (Quantum BioPharma Ltd.) in their 13F filings.

Which hedge fund owns the most QNTM?

The largest institutional holder of QNTM is AdvisorShares Investments LLC with $391K in shares.

Are institutions buying or selling QNTM?

This quarter, 7 institutions opened new positions in QNTM and 3 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.